XOMA Royalty Corporation (XOMA) - Net Assets
Based on the latest financial reports, XOMA Royalty Corporation (XOMA) has net assets worth $103.96 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($272.70 Million) and total liabilities ($168.74 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check XOMA Royalty Corporation liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $103.96 Million |
| % of Total Assets | 38.12% |
| Annual Growth Rate | 5.31% |
| 5-Year Change | -26.72% |
| 10-Year Change | N/A |
| Growth Volatility | 2323.31 |
XOMA Royalty Corporation - Net Assets Trend (1985–2025)
This chart illustrates how XOMA Royalty Corporation's net assets have evolved over time, based on quarterly financial data. Also explore XOMA asset base for the complete picture of this company's asset base.
Annual Net Assets for XOMA Royalty Corporation (1985–2025)
The table below shows the annual net assets of XOMA Royalty Corporation from 1985 to 2025. For live valuation and market cap data, see how much is XOMA Royalty Corporation worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $103.96 Million | +26.90% |
| 2024-12-31 | $81.92 Million | -7.66% |
| 2023-12-31 | $88.72 Million | -28.46% |
| 2022-12-31 | $124.01 Million | -12.59% |
| 2021-12-31 | $141.88 Million | +64.16% |
| 2020-12-31 | $86.42 Million | +96.47% |
| 2019-12-31 | $43.99 Million | +134.17% |
| 2018-12-31 | $18.79 Million | +224.66% |
| 2017-12-31 | $5.79 Million | +112.26% |
| 2016-12-31 | $-47.21 Million | -1944.61% |
| 2015-12-31 | $-2.31 Million | -174.51% |
| 2014-12-31 | $3.10 Million | +177.73% |
| 2013-12-31 | $-3.99 Million | -118.57% |
| 2012-12-31 | $21.47 Million | +43.01% |
| 2011-12-31 | $15.01 Million | -36.37% |
| 2010-12-31 | $23.59 Million | +34.61% |
| 2009-12-31 | $17.53 Million | +155.81% |
| 2008-12-31 | $-31.40 Million | -9974.53% |
| 2007-12-31 | $318.00K | +100.83% |
| 2006-12-31 | $-38.17 Million | -84.67% |
| 2005-12-31 | $-20.67 Million | +16.01% |
| 2004-12-31 | $-24.61 Million | -151.04% |
| 2003-12-31 | $48.21 Million | +524.23% |
| 2002-12-31 | $-11.37 Million | -183.45% |
| 2001-12-31 | $13.62 Million | +258.54% |
| 2000-12-31 | $-8.59 Million | +49.17% |
| 1999-12-31 | $-16.90 Million | -8550.00% |
| 1998-12-31 | $200.00K | -99.36% |
| 1997-12-31 | $31.20 Million | -10.09% |
| 1996-12-31 | $34.70 Million | +29.48% |
| 1995-12-31 | $26.80 Million | -38.39% |
| 1994-12-31 | $43.50 Million | -44.52% |
| 1993-12-31 | $78.40 Million | -11.41% |
| 1992-12-31 | $88.50 Million | -34.20% |
| 1991-12-31 | $134.50 Million | +409.47% |
| 1990-12-31 | $26.40 Million | -2.58% |
| 1989-12-31 | $27.10 Million | -9.06% |
| 1988-12-31 | $29.80 Million | -22.60% |
| 1987-12-31 | $38.50 Million | +220.83% |
| 1986-12-31 | $12.00 Million | -8.40% |
| 1985-12-31 | $13.10 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to XOMA Royalty Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 120545000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $89.00K | 0.09% |
| Other Comprehensive Income | $53.00K | 0.05% |
| Other Components | $1.33 Billion | 1274.79% |
| Total Equity | $103.96 Million | 100.00% |
XOMA Royalty Corporation Competitors by Market Cap
The table below lists competitors of XOMA Royalty Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Home Bancorp Inc
NASDAQ:HBCP
|
$505.30 Million |
|
Addiko Bank AG
VI:ADKO
|
$505.32 Million |
|
Bingshan Refrigeration & Heat Transfer Technologies Co Ltd
SHE:000530
|
$505.40 Million |
|
Stylam Industries Limited
NSE:STYLAMIND
|
$505.62 Million |
|
Sumitomo Mitsui Construction Co. Ltd
F:72S
|
$505.15 Million |
|
Cooper Stnd
NYSE:CPS
|
$505.14 Million |
|
Sichuan Fulin Transportation Group Co Ltd
SHE:002357
|
$505.07 Million |
|
POSCO M-TECH Co. Ltd
KQ:009520
|
$504.87 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in XOMA Royalty Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 81,921,000 to 103,960,000, a change of 22,039,000 (26.9%).
- Net income of 31,712,000 contributed positively to equity growth.
- Dividend payments of 5,472,000 reduced retained earnings.
- Share repurchases of 16,043,000 reduced equity.
- New share issuances of 4,342,000 increased equity.
- Other comprehensive income decreased equity by 20,000.
- Other factors increased equity by 7,520,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $31.71 Million | +30.5% |
| Dividends Paid | $5.47 Million | -5.26% |
| Share Repurchases | $16.04 Million | -15.43% |
| Share Issuances | $4.34 Million | +4.18% |
| Other Comprehensive Income | $-20.00K | -0.02% |
| Other Changes | $7.52 Million | +7.23% |
| Total Change | $- | 26.90% |
Book Value vs Market Value Analysis
This analysis compares XOMA Royalty Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 7.20x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.09x to 7.20x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-12-31 | $466.69 | $41.65 | x |
| 1986-12-31 | $490.28 | $41.65 | x |
| 1987-12-31 | $1323.93 | $41.65 | x |
| 1988-12-31 | $834.41 | $41.65 | x |
| 1989-12-31 | $615.13 | $41.65 | x |
| 1990-12-31 | $561.42 | $41.65 | x |
| 1991-12-31 | $2082.20 | $41.65 | x |
| 1992-12-31 | $1240.12 | $41.65 | x |
| 1993-12-31 | $1097.09 | $41.65 | x |
| 1994-12-31 | $595.92 | $41.65 | x |
| 1995-12-31 | $339.66 | $41.65 | x |
| 1996-12-31 | $320.38 | $41.65 | x |
| 1997-12-31 | $236.69 | $41.65 | x |
| 1998-12-31 | $1.40 | $41.65 | x |
| 1999-12-31 | $-96.20 | $41.65 | x |
| 2000-12-31 | $-39.82 | $41.65 | x |
| 2001-12-31 | $59.94 | $41.65 | x |
| 2002-12-31 | $-48.46 | $41.65 | x |
| 2003-12-31 | $192.68 | $41.65 | x |
| 2004-12-31 | $-87.00 | $41.65 | x |
| 2005-12-31 | $-68.85 | $41.65 | x |
| 2006-12-31 | $-119.34 | $41.65 | x |
| 2007-12-31 | $0.75 | $41.65 | x |
| 2008-12-31 | $-70.87 | $41.65 | x |
| 2009-12-31 | $30.98 | $41.65 | x |
| 2010-12-31 | $25.35 | $41.65 | x |
| 2011-12-31 | $9.50 | $41.65 | x |
| 2012-12-31 | $6.64 | $41.65 | x |
| 2013-12-31 | $-0.92 | $41.65 | x |
| 2014-12-31 | $0.54 | $41.65 | x |
| 2015-12-31 | $-0.39 | $41.65 | x |
| 2016-12-31 | $-7.84 | $41.65 | x |
| 2017-12-31 | $0.73 | $41.65 | x |
| 2018-12-31 | $2.24 | $41.65 | x |
| 2019-12-31 | $5.02 | $41.65 | x |
| 2020-12-31 | $7.51 | $41.65 | x |
| 2021-12-31 | $11.64 | $41.65 | x |
| 2022-12-31 | $10.87 | $41.65 | x |
| 2023-12-31 | $7.73 | $41.65 | x |
| 2024-12-31 | $7.00 | $41.65 | x |
| 2025-12-31 | $5.78 | $41.65 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently XOMA Royalty Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 30.50%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 60.81%
- • Asset Turnover: 0.19x
- • Equity Multiplier: 2.62x
- Recent ROE (30.50%) is above the historical average (-750.60%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | -36.64% | -65.75% | 0.49x | 1.14x | $-6.11 Million |
| 1986 | -389.17% | -46700.00% | 0.00x | 3.95x | $-47.90 Million |
| 1987 | -12.47% | -62.34% | 0.12x | 1.73x | $-8.65 Million |
| 1988 | -40.27% | -240.00% | 0.09x | 1.85x | $-14.98 Million |
| 1989 | -69.74% | -181.73% | 0.09x | 4.08x | $-21.61 Million |
| 1990 | -89.77% | -115.61% | 0.21x | 3.67x | $-26.34 Million |
| 1991 | -25.50% | -200.58% | 0.11x | 1.15x | $-47.75 Million |
| 1992 | -53.22% | -923.53% | 0.05x | 1.24x | $-55.95 Million |
| 1993 | -39.92% | -5216.67% | 0.01x | 1.20x | $-39.14 Million |
| 1994 | -79.54% | -2035.29% | 0.03x | 1.43x | $-38.95 Million |
| 1995 | -83.96% | -1875.00% | 0.03x | 1.53x | $-25.18 Million |
| 1996 | -83.86% | -808.33% | 0.06x | 1.66x | $-32.57 Million |
| 1997 | -50.64% | -85.87% | 0.28x | 2.08x | $-18.92 Million |
| 1998 | -23600.00% | -749.21% | 0.17x | 186.50x | $-47.22 Million |
| 1999 | 0.00% | -1908.33% | 0.08x | 0.00x | $-44.11 Million |
| 2000 | 0.00% | -441.69% | 0.15x | 0.00x | $-28.55 Million |
| 2001 | -205.89% | -162.28% | 0.20x | 6.32x | $-29.40 Million |
| 2002 | 0.00% | -111.01% | 0.42x | 0.00x | $-32.11 Million |
| 2003 | -121.65% | -240.26% | 0.21x | 2.47x | $-63.47 Million |
| 2004 | 0.00% | -2153.94% | 0.08x | 0.00x | $-76.48 Million |
| 2005 | 0.00% | 14.89% | 0.26x | 0.00x | $4.85 Million |
| 2006 | 0.00% | -175.74% | 0.32x | 0.00x | $-48.02 Million |
| 2007 | -3876.10% | -14.63% | 0.99x | 266.71x | $-12.36 Million |
| 2008 | 0.00% | -66.55% | 1.01x | 0.00x | $-42.10 Million |
| 2009 | 3.14% | 0.56% | 1.86x | 3.01x | $-1.20 Million |
| 2010 | -291.45% | -204.38% | 0.45x | 3.15x | $-71.12 Million |
| 2011 | -218.13% | -56.26% | 0.75x | 5.20x | $-34.24 Million |
| 2012 | -331.04% | -210.36% | 0.32x | 4.92x | $-73.21 Million |
| 2013 | 0.00% | -349.94% | 0.26x | 0.00x | $-123.66 Million |
| 2014 | -1235.91% | -203.02% | 0.21x | 28.92x | $-38.61 Million |
| 2015 | 0.00% | -37.16% | 0.74x | 0.00x | $-20.38 Million |
| 2016 | 0.00% | -962.08% | 0.19x | 0.00x | $-48.81 Million |
| 2017 | 252.26% | 27.70% | 1.17x | 7.77x | $14.02 Million |
| 2018 | -71.03% | -251.80% | 0.08x | 3.40x | $-15.22 Million |
| 2019 | -4.51% | -10.79% | 0.19x | 2.18x | $-6.38 Million |
| 2020 | 15.39% | 45.25% | 0.23x | 1.45x | $4.66 Million |
| 2021 | 11.14% | 41.40% | 0.23x | 1.17x | $1.61 Million |
| 2022 | -13.79% | -283.79% | 0.04x | 1.13x | $-29.51 Million |
| 2023 | -46.02% | -858.15% | 0.02x | 2.64x | $-49.70 Million |
| 2024 | -16.87% | -48.52% | 0.13x | 2.70x | $-22.01 Million |
| 2025 | 30.50% | 60.81% | 0.19x | 2.62x | $21.32 Million |
Industry Comparison
This section compares XOMA Royalty Corporation's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $112,382,454
- Average return on equity (ROE) among peers: -190.54%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| XOMA Royalty Corporation (XOMA) | $103.96 Million | -36.64% | 1.62x | $505.19 Million |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-27.92 Million | 0.00% | 0.00x | $98.85 Million |
| Abcellera Biologics Inc (ABCL) | $11.61 Million | 2.66% | 0.85x | $1.59 Billion |
| Abeona Therapeutics Inc (ABEO) | $1.80 Million | -188.89% | 0.33x | $309.44 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $70.43 Million | -172.28% | 0.74x | $181.29 Million |
| Abpro Holdings, Inc. (ABP) | $3.07 Million | -479.81% | 1.57x | $2.00 Million |
| Absci Corp (ABSI) | $179.13 Million | -57.56% | 0.19x | $795.12 Million |
| Arbutus Biopharma Corp (ABUS) | $136.85 Million | -50.75% | 0.43x | $854.72 Million |
| ABVC Biopharma Inc (ABVC) | $8.87 Million | -144.74% | 0.54x | $27.18 Million |
| Abivax SA American Depositary Shares (ABVX) | $7.19 Million | -844.90% | 9.51x | $9.67 Billion |
| ACADIA Pharmaceuticals Inc (ACAD) | $732.79 Million | 30.90% | 0.62x | $3.61 Billion |
About XOMA Royalty Corporation
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with co… Read more